Heartflow, Inc. (HTFL)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch HTFL
Latest sale
$4.2M
Nov 17 · Routine
Form 4 sales
29
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

7
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    Aug 21 2026

    Sold 27,230 shares at $50.00 ($1.4M)

    Farquhar John C.M., Chief Executive Officer

    10b5-1 planSold 7% of holdings ($19.4M position)360,814 shares left1.2x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Sep 3 +13 days

    Sold 33,416 shares at $49.85 ($1.7M)

    Verghese Vikram, Chief Financial Officer

    10b5-1 planSold 13.1% of holdings ($12.7M position)221,143 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleRoutine
    Sep 8 +5 days

    Sold 6,640 shares at $50.03 ($332k)

    Verghese Vikram, Chief Financial Officer

    10b5-1 planSold 3% of holdings ($11.1M position)214,503 shares leftFiling

  4. 4 Form 4 saleRoutine
    Sep 11 +3 days

    Sold 38,900 shares at $46.78 ($1.8M)

    Farquhar John C.M., Chief Executive Officer

    10b5-1 planSold 10.8% of holdings ($16.9M position)321,914 shares left1.7x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Sep 15 +4 days

    Sold 34,975 shares at $50.08 ($1.8M)

    Verghese Vikram, Chief Financial Officer

    10b5-1 planSold 16.3% of holdings ($10.7M position)179,528 shares leftFiling

  6. 6 Form 4 saleRoutine
    Sep 18 +3 days

    Sold 24,345 shares at $50.55 ($1.2M)

    Verghese Vikram, Chief Financial Officer

    10b5-1 planSold 13.6% of holdings ($9.1M position)155,183 shares left0.7x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Sep 18 same day

    Sold 19,682 shares at $50.15 ($987k)

    Rogers Campbell, Chief Medical Officer

    10b5-1 planSold 19.8% of holdings ($5M position)79,956 shares left0.5x usual sizeFiling

  8. 8 Form 4 saleRoutine
    Nov 17 +60 days

    Sold 111,412 shares at $37.86 ($4.2M)

    Rogers Campbell, Chief Medical Officer

    10b5-1 planSold 94.5% of holdings ($4.5M position)6,503 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (29)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for HTFL
Source
Nov 17, 2026Rogers CampbellChief Medical OfficerForm 4 sale111,412$4.2M94.5%RoutineSEC
Sep 18, 2026Rogers CampbellChief Medical OfficerForm 4 sale19,682$987k19.8%RoutineSEC
Sep 18, 2026Verghese VikramChief Financial OfficerForm 4 sale24,345$1.2M13.6%RoutineSEC
Sep 15, 2026Verghese VikramChief Financial OfficerForm 4 sale34,975$1.8M16.3%RoutineSEC
Sep 11, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale38,900$1.8M10.8%RoutineSEC
Sep 8, 2026Verghese VikramChief Financial OfficerForm 4 sale6,640$332k3.0%RoutineSEC
Sep 3, 2026Verghese VikramChief Financial OfficerForm 4 sale33,416$1.7M13.1%RoutineSEC
Aug 21, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale27,230$1.4M7.0%RoutineSEC
Aug 18, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale32,676$1.5M7.8%RoutineSEC
Aug 17, 2026Rogers CampbellChief Medical OfficerForm 4 sale9,219$380k9.6%RoutineSEC
Aug 14, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale15,560$608k3.6%RoutineSEC
Aug 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$639k4.9%RoutineSEC
Jul 15, 2026Rogers CampbellChief Medical OfficerForm 4 sale9,219$237k9.4%RoutineSEC
Jul 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$626k4.9%RoutineSEC
Jun 24, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale38,900$1.4M7.8%RoutineSEC
Jun 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$643k4.3%RoutineSEC
May 18, 2026Rogers CampbellChief Medical OfficerForm 4 sale9,219$261k10.5%RoutineSEC
May 11, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$657k4.2%RoutineSEC
Apr 30, 2026Bain Capital Life Sciences III General Partner, LLC10% ownerForm 4 sale2M$58.9M19.1%No planSEC
Apr 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$603k3.9%RoutineSEC
Apr 1, 2026Rogers CampbellChief Medical OfficerForm 4 sale64,533$1.6M44.3%RoutineSEC
Mar 19, 2026Rogers CampbellChief Medical OfficerForm 4 sale64,533$1.7M45.1%RoutineSEC
Mar 18, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale9,725$243k1.7%RoutineSEC
Mar 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale12,837$291k2.2%RoutineSEC
Mar 5, 2026Cullivan Julie ADirectorForm 4 sale9,122$228k25.1%RoutineSEC
Feb 12, 2026Rogers CampbellChief Medical OfficerForm 4 sale65,153$1.6M46.1%RoutineSEC
Feb 10, 2026Farquhar John C.M.Chief Executive OfficerForm 4 sale22,562$620k3.7%RoutineSEC
Feb 5, 2026Cullivan Julie ADirectorForm 4 sale8,000$219k18.0%RoutineSEC
Feb 4, 2026Bain Capital Life Sciences Investors, LLC10% ownerForm 4 sale2M$56.1M16.1%No planSEC